AVID RADIOPHARMACEUTICALS
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97360821
- Registration number
- 7014191
- Mark type
- Stylized text
- Filed
- 15 Apr 2022
- Published for opposition
- 26 Jul 2022
- Registered
- 28 Mar 2023
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances containing radioactive agents for medical purposes; radioactive diagnostic scanning agents for in vivo use for detection and monitoring of beta-amyloid plaque; radiopharmaceutical preparations for clinical, medical and research use for diagnosing and treating brain diseases and disorders in the field of brain plaque density; radioactive pharmaceutical preparations and non-radioactive medical reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use for diagnosing and treating brain diseases and disorders; radiopharmaceutical preparations for use in diagnosis of Alzheimer's disease
Owner
- Avid Radiopharmaceuticals, Inc., Philadelphia, PA, US
- Avid Radiopharmaceuticals, Inc., Philadelphia, PA, US
- Avid Radiopharmaceuticals, Inc., Philadelphia, PA, US
Prosecution history
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jan 2023 — USE AMENDMENT FILED
- 08 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2022 — PUBLISHED FOR OPPOSITION
- 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 22 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED